RSV hospitalizations down as Central IL enters respiratory virus season

RSV Hospitalizations Down as Central Illinois Enters Virus Season

A recent analysis by the Centers for Disease Control and Prevention (CDC) reveals that hospitalization rates for respiratory syncytial virus (RSV) among infants and young children have declined during the most recent RSV season. Experts attribute this trend to the growing availability of vaccines and antibody treatments aimed at protecting the youngest and most vulnerable.

Significant Decline in Hospitalizations

According to the CDC, hospitalizations among infants have decreased by 28% to 43% compared with RSV seasons prior to the COVID-19 pandemic. Pediatrician Kelsey Grimes of OSF HealthCare noted that fewer children are requiring intensive care or oxygen support as a result.

“But we have seen a drastic decrease in hospitalizations and ICU stays, which is usually when kids get the increased work of breathing and need oxygen and support.”

Preventative Advances and New Treatments

RSV remains one of the top causes of hospitalization for infants and young children in the United States. The virus can lead to serious respiratory illness, particularly among those with preexisting conditions. However, recent preventive tools are making a noticeable difference.

“These preventative options don’t stop RSV completely,” Grimes said.

Summary

CDC data highlight a noticeable drop in RSV hospitalizations among children, thanks to new immunization options that strengthen early protection and reduce the severity of illness.

Author’s Summary: RSV cases among infants have declined notably in the U.S., with vaccines and antibody therapies significantly reducing hospital stays and severe outcomes.

more

wandtv.com wandtv.com — 2025-11-08

More News